References
Chen M, Zhuang J, Yang C, Zhang L, Wang W, Cai H, Yu Y, Li J, Zhou D, Han B (2020) Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia. Ann Hematol 99:1141–1143
Fadlallah J, Michel M, Crickx E, Limal N, Costedoat N, Malphettes M, Fieschi C, Galicier L, Oksenhendler E, Godeau B, Audia S, Mahévas M (2019) Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia. Br J Haematol 187:124–128
Knight T, Ravindranath Y, Callaghan MU (2020) Successful treatment of an adolescent male with severe refractory evans syndrome using bortezomib-based. Therapy J Pediatr Hematol Oncol 42:110–113
Author information
Authors and Affiliations
Contributions
SJ and PRJA reviewed the data, SJ drew the graphs, and PRJA wrote the article that SJ reviewed and approved.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
The patient gave written consent for her case to be published on a medical journal.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ames, P.R.J., Jeffrey, S. Bortezomib and rituximab in multiply relapsed primary warm autoimmune hemolytic anemia. Ann Hematol 100, 2415–2416 (2021). https://doi.org/10.1007/s00277-020-04135-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-04135-x